Abstract
Object
Quantitative assessment of liver fat is highly relevant to preclinical liver research and should ideally be performed non-invasively. This study aimed to compare three non-invasive Magnetic Resonance (MR) and two histopathological methods against the reference standard of biochemically determined liver triglyceride content (LTC).
Materials and methods
A total of 50 mice [21 C57Bl/6OlaHsd mice (C57Bl/6), nine low-density lipoprotein (LDL) receptor knock-out −/− (LDL −/−) mice and 20 C57BL/6 mice] received either a high-fat, high-fat-high-cholesterol or control diet, respectively. Mice were examined 4, 8 or 12 weeks into the diet using MR [1H-MR Spectroscopy, Proton Density Fat Fraction (PDFF), mDixon] and histopathological methods (visual scoring or digital image analysis (DIA) of Oil-Red-O (ORO) stained liver sections). Correlations [Pearson’s coefficient (r)] were studied with respect to LTC.
Results
Microvesicular steatosis was seen in 42/50 mice. 1H-MRS values showed normal to moderately elevated liver fat content. Visual scoring and DIA of ORO-sections correlated moderately with LTC at r = 0.59 and r = 0.49 (P < 0.001), respectively. 1H-MRS, PDFF and mDixon correlated significantly better, at r = 0.74, r = 0.75 and r = 0.82, respectively.
Conclusion
Non-invasively determined MR measures of normal to moderately elevated liver fat in mice had a higher correlation with LTC than invasive histopathological measures. Where available, MR is the preferred method for fat quantification.
Similar content being viewed by others
Abbreviations
- DIA:
-
Digital image analysis
- H&E:
-
Haematoxylin and eosin
- LTC:
-
Liver triglyceride content
- MRI:
-
Magnetic Resonance Imaging
- 1H-MRS:
-
1H Magnetic Resonance Spectroscopy
- NAFLD:
-
Non-alcoholic fatty liver disease
- NAS:
-
NAFLD Activity Score
- NASH:
-
Non-alcoholic steatohepatitis
- ORO:
-
Oil Red-O
References
Franzen LE, Ekstedt M, Kechagias S, Bodin L (2005) Semiquantitative evaluation overestimates the degree of steatosis in liver biopsies: a comparison to stereological point counting. Mod Pathol 18:912–916
El-Badry AM, Breitenstein S, Jochum W, Washington K, Paradis V, Rubbia-Brandt L, Puhan MA, Slankamenac K, Graf R, Clavien PA (2009) Assessment of hepatic steatosis by expert pathologists: the end of a gold standard. Ann Surg 250:691–697
Bancroft JD, Stevens A (2007) Theory and practice of histological techniques. Churchill Livingstone, Edinburgh
Levene AP, Kudo H, Armstrong MJ, Thursz MR, Gedroyc WM, Anstee QM, Goldin RD (2012) Quantifying hepatic steatosis—more than meets the eye. Histopathology 60:971–981
Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313–1321
Kumar Srivastava N, Pradhan S, Mittal B, Kumar R, Nagana Gowda GA (2006) An improved, single step standardized method of lipid extraction from human skeletal muscle tissue. Anal Lett 39:297–315
Reeder SB, Cruite I, Hamilton G, Sirlin CB (2011) Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging 34:729–749
Marsman HA, Heger M, Kloek JJ, Nienhuis SL, van Werven JR, Nederveen AJ, Ten Kate FJ, Stoker J, van Gulik TM (2011) Reversal of hepatic steatosis by omega-3 fatty acids measured non-invasively by 1H-magnetic resonance spectroscopy in a rat model. J Gastroenterol Hepatol 26:356–363
Bohte AE, van Werven JR, Bipat S, Stoker J (2011) The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis. Eur Radiol 21:87–97
van Werven JR, Marsman HA, Nederveen AJ, Smits NJ, ten Kate FJ, van Gulik TM, Stoker J (2010) Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy. Radiology 256:159–168
Permutt Z, Le TA, Peterson MR, Seki E, Brenner DA, Sirlin C, Loomba R (2012) Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease—MRI accurately quantifies hepatic steatosis in NAFLD. Aliment Pharmacol Ther 36:22–29
Kim H, Taksali SE, Dufour S, Befroy D, Goodman TR, Petersen KF, Shulman GI, Caprio S, Constable RT (2008) Comparative MR study of hepatic fat quantification using single-voxel proton spectroscopy, two-point dixon and three-point IDEAL. Magn Reson Med 59:521–527
Machann J, Thamer C, Schnoedt B, Stefan N, Haring HU, Claussen CD, Fritsche A, Schick F (2006) Hepatic lipid accumulation in healthy subjects: a comparative study using spectral fat-selective MRI and volume-localized 1H-MR spectroscopy. Magn Reson Med 55:913–917
Hockings PD, Changani KK, Saeed N, Reid DG, Birmingham J, O’Brien P, Osborne J, Toseland CN, Buckingham RE (2003) Rapid reversal of hepatic steatosis, and reduction of muscle triglyceride, by rosiglitazone: MRI/S studies in Zucker fatty rats. Diabetes Obes Metab 5:234–243
van Werven JR, Marsman HA, Nederveen AJ, ten Kate FJ, van Gulik TM, Stoker J (2012) Hepatic lipid composition analysis using 3.0-T MR spectroscopy in a steatotic rat model. Magn Reson Imaging 30:112–121
Szczepaniak LS, Babcock EE, Schick F, Dobbins RL, Garg A, Burns DK, McGarry JD, Stein DT (1999) Measurement of intracellular triglyceride stores by 1H spectroscopy: validation in vivo. Am J Physiol 276:E977–E989
Szczepaniak LS, Nurenberg P, Leonard D, Browning JD, Reingold JS, Grundy S, Hobbs HH, Dobbins RL (2005) Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 288:E462–E468
Bieghs V, Van Gorp PJ, Wouters K, Hendrikx T, Gijbels MJ, van Bilsen M, Bakker J, Binder CJ, Lutjohann D, Staels B, Hofker MH, Shiri-Sverdlov R (2012) LDL receptor knock-out mice are a physiological model particularly vulnerable to study the onset of inflammation in non-alcoholic fatty liver disease. PLoS One 7:e30668. doi:10.1371/journal.pone.0030668
Zaitoun AM, Al Mardini H, Awad S, Ukabam S, Makadisi S, Record CO (2001) Quantitative assessment of fibrosis and steatosis in liver biopsies from patients with chronic hepatitis C. J Clin Pathol 54:461–465
Livingstone R, Begovatz P, Link S, Nowotny B, Klueppelholz B, Giani G, Bunke J, Roden M, Hwang J et al (2012) Pancreatic and hepatic fat measurements using 1H MRS and mDIXON with flexible echo times. In: Proceedings of the 20th scientific meeting, International Society for Magnetic Resonance in Medicine, Melbourne, pp 1301
Bydder M, Yokoo T, Hamilton G, Middleton MS, Chavez AD, Schwimmer JB, Lavine JE, Sirlin CB (2008) Relaxation effects in the quantification of fat using gradient echo imaging. Magn Reson Imaging 26:347–359
Liu CY, McKenzie CA, Yu H, Brittain JH, Reeder SB (2007) Fat quantification with IDEAL gradient echo imaging: correction of bias from T 1 and noise. Magn Reson Med 58:354–364
Hamilton G, Yokoo T, Bydder M, Cruite I, Schroeder ME, Sirlin CB, Middleton MS (2011) In vivo characterization of the liver fat 1H MR spectrum. NMR Biomed 24:784–790
Rosset A, Spadola L, Pysher L, Ratib O (2006) Informatics in radiology (infoRAD): navigating the fifth dimension: innovative interface for multidimensional multimodality image navigation. Radiographics 26:299–308
Yokoo T, Shiehmorteza M, Hamilton G, Wolfson T, Schroeder ME, Middleton MS, Bydder M, Gamst AC, Kono Y, Kuo A, Patton HM, Horgan S, Lavine JE, Schwimmer JB, Sirlin CB (2011) Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T. Radiology 258:749–759
Bohte AE, Koot BG, van der Baan-Slootweg OH, van Werven JR, Bipat S, Nederveen AJ, Jansen PL, Benninga MA, Stoker J (2012) US cannot be used to predict the presence or severity of hepatic steatosis in severely obese adolescents. Radiology 262:327–334
Naressi A, Couturier C, Devos JM, Janssen M, Mangeat C, de Beer R, Graveron-Demilly D (2001) Java-based graphical user interface for the MRUI quantitation package. Magn Reson Mater Phy 12:141–152
Donner A, Zou GY (2002) Testing the equality of dependent intraclass correlation coefficients. J R Stat Soc D-Stat 51:367–379
Goodman ZD (2007) Grading and staging systems for inflammation and fibrosis in chronic liver diseases. J Hepatol 47(4):598–607
Hines CD, Yu H, Shimakawa A, McKenzie CA, Warner TF, Brittain JH, Reeder SB (2010) Quantification of hepatic steatosis with 3-T MR imaging: validation in ob/ob mice. Radiology 254:119–128
Hu HH, Bornert P, Hernando D, Kellman P, Ma J, Reeder S, Sirlin C (2012) ISMRM workshop on fat-water separation: insights, applications and progress in MRI. Magn Reson Med 68:378–388
Tandra S, Yeh MM, Brunt EM, Vuppalanchi R, Cummings OW, Unalp-Arida A, Wilson LA, Chalasani N (2011) Presence and significance of microvesicular steatosis in nonalcoholic fatty liver disease. J Hepatol 55:654–659
Hamilton G, Middleton MS, Bydder M, Yokoo T, Schwimmer JB, Kono Y, Patton HM, Lavine JE, Sirlin CB (2009) Effect of PRESS and STEAM sequences on magnetic resonance spectroscopic liver fat quantification. J Magn Reson Imaging 30:145–152
Acknowledgments
The authors thank N.M.A. Tiel and ARIA-personnel for assistance with animal handling, G.C.M. Grinwis MD, Ph.D. for discussions on mice pathology, M. Froeling Ph.D. for assistance with the DIA–ORO, C.B. Sirlin MD for distributing the Lipoquant plugin for OsiriX, and K.M. Moerman Ph.D. for assistance with revising the manuscript.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Runge, J.H., Bakker, P.J., Gaemers, I.C. et al. Measuring liver triglyceride content in mice: non-invasive magnetic resonance methods as an alternative to histopathology. Magn Reson Mater Phy 27, 317–327 (2014). https://doi.org/10.1007/s10334-013-0414-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10334-013-0414-3